Navigation Links
Effie Toshav Joins Fenwick - Broadens Life Sciences Service Platform
Date:5/14/2012

MOUNTAIN VIEW, Calif., May 14, 2012 /PRNewswire/ -- Fenwick & West, a leading technology and life sciences law firm, is pleased to announce that Effie Toshav has joined the firm as a partner in its Life Sciences Group. Ms. Toshav's national practice focuses on advising life sciences clients as a strategic counselor on a broad range of legal issues and transactions. Formerly senior vice president, general counsel and secretary at AVI BioPharma, Ms. Toshav is based in Fenwick's Seattle office.

"Effie's reputation throughout the life sciences industry as a trusted corporate counsel, deal maker and sophisticated legal practitioner is matchless," said Fenwick Chairman Gordon Davidson. "Our clients will benefit greatly from the breadth of her experience as a seasoned lawyer and as a senior executive at both public and private biopharmaceutical companies. We are very proud to have her join the firm."

"Fenwick's appeal is readily apparent to those in the life sciences industry," said Effie Toshav. "It's an innovative firm with a platform uniquely suited to serving emerging companies and their legal needs. I've seen firsthand how the structure of the firm and the culture of collaboration at Fenwick result in better service to clients."

"It's a wonderful development to have Effie joining the team," said Stephen Graham, co-chair of Fenwick's Life Sciences Group. "Her top tier experience and reputation in the industry for creative deal making and thoughtful legal counsel are a great fit with the firm and with our plans for national growth in this practice area."

Before becoming general counsel at AVI BioPharma, Ms. Toshav was a partner at Wilson Sonsini Goodrich & Rosati. Prior to private practice, she was on the management team of biotechnology company GlycoFi and played a significant role in the $400 million sale of the company to Merck in 2006. Ms. Toshav received a B.A. in political science from Stanford University and a J.D. from Cornell Law School.

About the Fenwick & West Life Sciences Group

Fenwick & West's Life Sciences Group consists of more than 60 attorneys and scientists who provide a broad mix of corporate, intellectual property and litigation services to private companies, public companies, investors and research institutions. Many of our Life Sciences Group attorneys have had scientific and research experience prior to their legal careers, and a number have doctorate degrees in disciplines such as molecular biology, organic chemistry, electrical engineering, and immunology. The firm was ranked as a "Top Technology & Life Sciences Law Firm" by InterContinental Finance Magazine in its 2011 Highly Commended - Top Tier Firm listing.

To view the release, visit: http://www.fenwick.com/Media/Pages/Effie-Toshav-Joins-Fenwick---Broadens-Life-Sciences-Service-Platform.aspx

CONTACT:  Jennifer Shanks, 408-827-8033, jennifer@leappr.com.


'/>"/>
SOURCE Fenwick & West
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Daiichi Sankyo/Eli Lillys Effient and Astrazenecas Ticagrelor May Offer Advantages in the Treatment of Post-Myocardial Infarction
2. New Updates to AHA/ACC/SCAI Clinical Guidelines Recommend Treatment with Effient(R) for Patients with Acute Coronary Syndromes Managed with PCI
3. Sheffield Bio-Science Wins 2010 Lilly Global Supplier Award
4. Mortality Data Presented for Patients Treated with Efient®/Effient® (Prasugrel) Who Underwent Isolated Coronary Artery Bypass Surgery
5. Mortality Data Presented for Patients Treated with Effient® Who Underwent Isolated Coronary Artery Bypass Surgery
6. Sheffield Bio-Science and Wockhardt Announce Worldwide Exclusive Partnership to Supply Recombinant Insulin to Cell Culture Market
7. Effient® Added to Updated ACCF/AHA Clinical Guidelines for ACS-PCI Patients with Unstable Angina and Non-ST Segment Myocardial Infarction
8. New Analysis of Data Presented at AHA Regarding Effect of Effient® (Prasugrel) on Cardiovascular Events in STEMI Patients According to Timing of PCI
9. General Wesley Clark Joins Immtech as Consulting Strategic Advisor
10. Actress and New Mom Keri Russell Joins PKIDs to launch Silence the Sounds of Pertussis Campaign
11. Video: Actress and New Mom Keri Russell Joins PKIDs to Launch Silence the Sounds of Pertussis Campaign
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... OAKLAND, N.J. , June 24, 2016 /PRNewswire/ ... in the design, development and manufacturing of collagen ... and regeneration announced today that Bill Messer ... Sales and Marketing to further leverage the growing ... surgery medical devices. Bill joins the ...
(Date:6/24/2016)... , June 24, 2016 The Academy ... of recommendations that would allow biopharmaceutical companies ... with entities that make formulary and coverage decisions, a ... "value" of new medicines. The recommendations address ... not appear on the drug label, a prohibition that ...
(Date:6/24/2016)... , June 24, 2016   Pulmatrix, Inc ... company developing innovative inhaled drugs, announced today that it ... Russell Investments reconstituted its comprehensive set of U.S. ... "This is an important milestone for Pulmatrix," said ... increase shareholder awareness of our progress in developing drugs ...
Breaking Medicine Technology:
(Date:6/24/2016)... ... 2016 , ... A recent article published June 14 on E ... goes on to state that individuals are now more comfortable seeking to undergo not ... as calf and cheek reduction. The Los Angeles area medical group, Beverly Hills Physicians ...
(Date:6/24/2016)... ... 2016 , ... June 19, 2016 is World Sickle Cell Observance Day. In ... benefits of holistic treatments, Serenity Recovery Center of Marne, Michigan, has issued ... Sickle Cell Disease (SCD) is a disorder of the red blood cells, which can ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Pulmonary Hypertension Association (PHA) ... will receive two significant new grants to support its work to advance research ... anniversary by recognizing patients, medical professionals and scientists for their work in fighting ...
(Date:6/24/2016)... CA (PRWEB) , ... June 24, 2016 , ... ... is now offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive experience ... Damon brackets , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation is ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and ... that call for a minimum wage raise to $12 an hour by 2020 and then ... will restore the lost value of the minimum wage, assure the wage floor does not ...
Breaking Medicine News(10 mins):